跳至主要内容
临床试验/NCT02285972
NCT02285972已完成4 期

Efficacy of Intravenous Dexketoprofen and Tenoxicam on Propofol Associated Injection Pain

T.C. ORDU ÜNİVERSİTESİ1 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2014年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
118
试验地点
1
主要终点
Verbal Pain Score

研究概览

简要总结

Propofol remains the most common drug for induction of general anaesthesia, although it causes considerable pain or discomfort on injection. Anesthesia providers have attempted a large number of remedies to prevent this pain on injection. Previously explored ideas include injecting propofol into larger veins, warming of the hand with hot packs, and intravenous pretreatment with numerous other medications. No studies to date have looked at the dexketoprofen and tenoxicam for the pretreatment of pain on injection caused by propofol. The investigators propose studying the use of dexketoprofen and tenoxicam for pretreatment of propofol related pain on injection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status 1 and 2
  • 18 - 65 years
  • general anesthesia scheduled for elective surgery

排除标准

  • age < 18 years, > 65 years
  • pregnancy
  • patients requiring a rapid sequence induction
  • refusal to participate and patients already participating in another study
  • allergy to study drugs
  • communication difficulty
  • psychiatric and neurolojic disorders
  • use of analgesics or sedative drugs within 24 hours before surgery.
  • emergency surgery
  • history of drug or alcohol abuse
  • ASA 3 and above

研究组 & 干预措施

saline

Placebo Comparator

干预措施: saline (Drug)

dexketoprofen

Active Comparator

干预措施: dexketoprofen (Drug)

tenoxicam

Active Comparator

干预措施: tenoxicam (Drug)

结局指标

主要结局

Verbal Pain Score

时间窗: Approximately one minute following administration of propofol.

Facial Pain Score

时间窗: Approximately one minute following administration of propofol.

次要结局

未报告次要终点

研究者

发起方
T.C. ORDU ÜNİVERSİTESİ
申办方类型
Other
责任方
Principal Investigator
主要研究者

özgür yağan

MD, assistant professor

T.C. ORDU ÜNİVERSİTESİ

研究点 (1)

Loading locations...

相似试验